Prevalence and Risk Factors of Mitral, Tricuspid, and Aortic Regurgitation: A Population-Based Study from Rural Northeast China

Am J Cardiol. 2023 Dec 15:209:156-162. doi: 10.1016/j.amjcard.2023.09.107. Epub 2023 Oct 22.

Abstract

The population-based studies on the epidemiologic features of valvular regurgitation in Northeast China are scarce. We aim to estimate the prevalence and risk factors of mitral regurgitation (MR), tricuspid regurgitation (TR), and aortic regurgitation (AR) in a general population from rural Northeast China. Valvular regurgitation was assessed by color flow Doppler echocardiography in a population-based survey of 11,278 participants aged ≥35 years in rural areas of Liaoning Province during 2012 to 2013. The prevalence of mild or greater MR and TR were 1.6% and 1.5%, respectively. Trace or greater AR was present in 4.1% of the participants. In the multivariable regression model, older age, left atrial dimension, low left ventricular (LV) ejection fraction, and fasting plasma glucose were associated with higher risk of MR in men, whereas only older age and left atrial dimension increased the risk in women. Body mass index was found to be a protective factor for MR in women (odds ratio 0.847, 95% confidence interval 0.741 to 0.969). TR was independently associated with age, heart rate, low LV ejection fraction, current drinking status, and high-density lipoprotein cholesterol. The risk for AR significantly increased with age in both genders. LV mass index and aortic dimension increased the risk of AR in males, and females with higher LV mass index and high-density lipoprotein cholesterol had an increased risk for AR. In both genders, systolic blood pressure presented as a risk factor for AR, while diastolic blood pressure as a protective factor. In this large Chinese population-based study, we found remarkably low prevalence of valvular regurgitation, adding evidence for estimating disease burden and making policy strategies in Northeast China.

Keywords: aortic regurgitation; mitral regurgitation; prevalence; risk factors; tricuspid regurgitation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aortic Valve Insufficiency* / diagnostic imaging
  • Aortic Valve Insufficiency* / epidemiology
  • Atrial Fibrillation*
  • Cholesterol
  • Female
  • Humans
  • Lipoproteins, HDL
  • Male
  • Mitral Valve Insufficiency* / diagnostic imaging
  • Mitral Valve Insufficiency* / epidemiology
  • Prevalence
  • Risk Factors
  • Tricuspid Valve Insufficiency* / diagnostic imaging
  • Tricuspid Valve Insufficiency* / epidemiology

Substances

  • Lipoproteins, HDL
  • Cholesterol